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Abstract 
Aim: IL-1β was considered as an important inflammatory cytokine in diabetic cardiovascular complications. DCM is 
one of the major manifestations of diabetic cardiovascular complications whose specific mechanisms are still unclear. 
In this study, we investigated the role of IL-1β in myocytes apoptosis in DCM.
Methods: In the in vitro study, high- glucose medium and/or IL-1β were used to incubate the isolated primary 
myocytes. siRNA was used to knockdown the irak2 gene expression. Apoptosis was evaluated by Hoechst and TUNEL 
staining. In the in vivo study, DCM in rats was induced by STZ injection and confirmed by cardiac hemodynamic 
determinations. The IL-1 receptor antagonist, IL-1Ra was also used to treat DCM rats. Myocardial apoptosis was 
assessed by TUNEL assay. In both in vitro and in vivo studies, expression levels of GRP-78, IRAK-2 and CHOP were ana-
lyzed by Western Blotting. ELISA was employed to exam the IL-1β content in serum and cell supernatants.
Results: Myocytes were not identified as the source of IL-1β secretion under high- glucose incubation. High glucose 
incubation and/or IL-1β incubation elevated ER- stress mediated myocytes apoptosis which was attenuated by irak2 
silencing. Dramatically increased circulating and myocardial IL-1β levels were found in DCM rats which stimulated 
activation of ER stress and lead to elevated myocytes apoptosis. The administration of IL-1Ra, however, attenuated 
IRAK2/CHOP induced apoptosis without affecting fasting blood glucose concentration.
Conclusions: Elevated circulating IL-1β contributed to promote ER stress- induced myocytes apoptosis by affecting 
IRAK-2/CHOP pathway in DCM.
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Background
In worldwide, the rapidly growing morbidity and mortal-
ity of both type-1 and type-2 diabetes are growing fast [1, 
2]. Among the complications of diabetes, cardiovascular 
complications were considered contributing largely to the 
mortality of diabetes because of diabetic cardiomyopathy 
(DCM), myocardial infarction and sudden cardiac death 
[3]. As one of the most important manifestations of dia-
betic cardiovascular complications, DCM is character-
ized by impaired cardiac diastolic and systolic functions 
[4]. Though the mechanisms of DCM are still unclear, 
our previous studies proved that contractile units lost 
which was caused by myocardial apoptosis took respon-
sibility for cardiac dysfunction in DCM [5].
Accumulating studies suggested that diabetes was one 
of the inflammatory diseases, which was evidenced by the 
elevated levels of cytokines and chemokines in patients 
with diabetes [6]. Further studies reported inflammatory 
cytokines such as interleukin-1β (IL-1β) were considered 
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predictive of prognosis of type- 2 diabetes [7]. On one 
hand, excessive IL-1β was found produced by T cells and 
pancreatic β-cells under circumstance of hyperglycemia 
[8]; on the other hand, the elevated IL-1β induced apop-
tosis of β-cells to further impair insulin secretion [6]. 
Therefore, IL-1β plays an important role in the patho-
genesis of diabetes. Other studies indicated that cardio-
myocyte apoptosis was induced by extracellular IL-1β [9]. 
Results from these studies aroused our interests to imple-
ment further investigation on the association between 
IL-1β and cardiovascular complications of diabetes, 
DCM especially.
As one of the critical organelles, endoplasmic reticu-
lum (ER) carries out fundamental biological functions 
including protein folding, protein modification, lipid 
synthesis and calcium signaling [10]. Under stressful 
conditions, as the unfolded or misfolded protein accu-
mulating in ER lumen, ER stress is triggered to initiate 
pathological changes. Our previous study confirmed 
that ER stress was one of the critical triggers of cardio-
myocyte apoptosis in DCM [11], which was responsible 
for the myocardial cell loss in DCM [11, 12]. As a result 
of signaling activation in ER stress, pro- apoptotic fac-
tors such as C/EBP homologous protein (CHOP) would 
lead to programmed cell death [13]. The signaling net-
work activating CHOP in ER stress is quite complex and 
still not completely clear. A recent study reported that 
expression of interleukin-1 receptor-associated kinase-2 
(IRAK-2) was increased during ER stress and further pro-
moted CHOP- induced cell apoptosis [14]. Other previ-
ous investigation established the notion that IRAK2 was 
the down-stream effector of IL-1 signaling which was one 
of the triggers of ER stress [15]. These results provided 
us more clues to study the inflammatory signaling in ER 
stress- mediated cell apoptosis.
After binding with IL-1β, the IL-1 receptor (IL-1R) is 
activated and then associates an accessory protein named 
AcP [16]. The complex further recruits the adapter pro-
tein myeloid differentiation protein 88 (MyD88) to initi-
ate IRAK-2 pathways [17]. Thus, we hypothesize that the 
generated circulating IL-1β would promote ER stress- 
induced myocytes apoptosis via IRAK-2/CHOP pathway. 
In order to testify our hypothesis, we implemented both 
in vivo and in vitro experiments. In the in vitro study, ER 
stress- induced apoptosis was evaluated in primary myo-
cytes which were treated with high glucose and IL-1β. 
The role of IRAK-2 was evaluated by IRAK-2 siRNA 
knockdown. In the in  vivo study, DCM was induced by 
streptozotocin (STZ) injection. The circulating IL-1β 
was detected and its role in ER stress was further inves-
tigated by administration of IL-1β antagonist. We believe 
that results in the current study would be significant in 
interpretating the association between inflammation and 
DCM and benefit indentifying potential novel molecular 
targets for DCM therapy.
Methods
Cell culture
Myocytes were isolated form neonate male Sprague–
Dawley (SD) supplied by the Experimental Animal 
Center of Xi’an Jiaotong University. The isolation pro-
cedure was in accordance with the description in our 
previous studies [11]. Briefly, the hearts were harvested 
after rats were sacrificed. Heart was treated by perfusion 
with Liberase (4.5 mg/ml, Roche). Cells were cultured in 
medium containing minimum essential medium (MEM) 
containing Hank’s buffered salt solution (HyClone), 
bovine calf serum (5 %, Gibco), l-glutamine (2 mmol/L, 
Invitorgen), CaCl2 (1.8 mmol/L, Sigma), penicillin/strep-
tomycin (100  U/ml, Sigma) and 2,3-butanedione mon-
oxime (10 mmol/L, Sigma) for 1 h. Then the medium was 
replaced by medium containing MEM (Gibco), myocyte 
bovine serum albumin (0.1  mg/ml, Invitrogen), l-glu-
tamine (2 mmol/L, Invitrogen) and penicillin/streptomy-
cin (100 U/ml, Sigma) in an incubator proving humidified 
environment and fresh air (0.5 % CO2) at 37 °C.
Small interfering RNA (siRNA) treatment
In this study, gene of IRAK2 was silenced by using 
RNA interfering (RNAi) technique by siRNA. Target-
ing sequence of siRNA against irak-2 was 5′-CTTCGC-
CTCCTACGTGATCAC-3′ (GenePharma). The scramble 
siRNA was 5′-GAAACAGACGACGTTGACAA-3′ 
(GenePharma) which was used as negative control [14]. 
siRNA was transfected into myocytes at final concen-
tration of 12.5 mmol/L with the assistance of HiPerFect 
siRNA transfection reagent (Qiagen) according to man-
ufacturer’s instructions. After 24-h incubation, the cells 
were ready for subsequent experiments.
Cell treatment
When cell populations reached confluence above 60  %, 
the cultured cells were respectively incubated with nor-
mal glucose medium (D-type glucose concentration 
at 5.5  mmol/L) or high glucose medium (D-type glu-
cose concentration at 33 mmol/L) for 48 h and/or IL-1β 
(20 ng/ml, sigma) for 12 h.
Animals
Thirty 10-week old male SD rats with mean body weight 
at (305  ±  15)  g (Animal Experimental Center of Xi’an 
Jiaotong University) were used in this study. The mean 
fasting glucose concentration of the selected animals was 
(113.29  ±  25.17)  mg/dL. Animals were raised in inde-
pendent polypropylene cages under controlled conditions 
(artificial alternating 12-h dark- light cycle, temperature 
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at 25 ± 1  °C, humidity at 65 ± 4 %) for 1 week prior to 
experiments. The animals were free to standard rodent 
food and sterilized water. All animal experimental proce-
dures were carried out according to protocols approved 
by Medical Animal Research Ethics Committee at Xi’an 
Jiaotong University.
Animal treatment
STZ injections (250/20  ml) were acquired from CSPC 
Pharma. Diabetes of rats was induced by single intraperi-
toneal injection of STZ (65 mg/Kg bodyweight, dissolved 
in sodium citrate buffer with pH  =  4.5); recombinant 
IL-1Ra (10  mg/Kg bodyweight, Sigma) was adminis-
trated subcutaneously once per day for 1  week accord-
ing to previous studies [18] and our pre-experiments 
(Fig.  1A). Equal volume of physiological saline (equaled 
to the volume of used STZ injection) was tittered into 
sodium citrate buffer solution and administrated as con-
trol. Diabetic animal model establishment was confirmed 
by fasting blood glucose concentration tests via tail vein 
(One Touch SureStep Meter, LifeScan) 4 weeks after STZ 
injections. 6 weeks after modeling, the invasive hemody-
namic cardiac function evaluation was carried out and 
the rats were sacrificed to acquire samples.
Invasive hemodynamic cardiac function evaluation
After anesthetized by intraperitoneal injection of chloral 
hydrate (10  %, 0.03  ml/Kg bodyweight), invasive hemo-
dynamic determination was conducted in accordance 
with our previous studies [11]. Through the right carotid 
artery, a Mikro Tip catheter transducer (Millar Instru-
ments) was intubated into left ventricle and connected 
to Powerlab 4/25 Biological Analysis System (AD Instru-
ment), then the left ventricular systolic pressure (LVSP) 
and left ventricular end- diastolic pressure (LVEDP) were 
measured and recorded.
IL‑1β concentration determination
IL-1β concentration in serum or cell culture supernatants 
were determined by using specific rat enzyme linked-
immuno-sorbent assay (ELISA) kit “Quantkine Rat 
IL-1β” (R&D). The detection procedure was carried out 
according to the manufacturer’s instructions. The con-
centration results were calculated based on the absorb-
ance value and standard curves.
Cardiomyocyte apoptosis assessment
Hoechst staining
In cultured myocytes, Hoechst fluorescent staining was 
used to detect the apoptosis. Cultured cells were har-
vested and fixed by paraformaldehyde (4  %) at room 
temperature for 1 h. Then cTnI (Abcam) conjugated with 
Alexa Fluor 488 (Abcam) and Hoechst 33342 (5 μmol/L, 
Sigma) was used to incubate the myocytes at 37  °C for 
30 min in a humidified dark chamber. Then the fluores-
cent images were captured by a fluorescence microscope 
(Nikon).
TUNEL staining
Myocytes apoptosis in cardiac tissue was examined by 
terminal dUTP trasferase nick end labeling (TUNEL). 
The paraffin- embedded 5-μm thick sections of car-
diac tissue were digested by proteinase K (20 μmol/L, 
Sigma) and fixed by paraformaldehyde (4  %, Solarbio) 
and then permeabilized by Triton X-100 (0.1 %, Sigma- 
Aldrich). A TUNEL assay kit (Roche) was employed to 
detect the apoptotic cells per manufacturer’s instruc-
tions. Briefly, the cryo- sections were washed by PBS 
and then incubated with prepared TUNEL solution for 
1  h at 37  °C in a dark chamber. The TUNEL-positive 
cells were observed and counted under a light micro-
scope (Motic). For in vitro apoptosis evaluation, the In 
Situ Cell Death Detection kit (Roche) was used. Briefly, 
the cultured myocytes were fixed with paraformalde-
hyde (4 %, Solarbio) and then permeabilized with Tri-
ton X-100 (0.1  %, Sigma- Aldrich). According to the 
manufacturer’s protocols, the cells were incubated 
with TUENL staining solution for 1 h. The nuclei were 
stained with DAPI (Beyotime). The TUNEL positive 
cells were observed and counted under a fluorescence 
microscope (Nikon).
Western blotting
The homogenates were acquired after cardiac tissue or 
myocytes were homogenized by RIPA lysis buffer sys-
tem (Santa Cruz) with PMSF (Santa Cruz). After cen-
trifugation, the supernatants were separated from the 
homogenates. Protein concentration in supernatants 
was measured by a BCA protein assay kit (Pierce). The 
protein was separated by vertical electrophoresis in 
SDS gels and then transferred to polyvinylidene fluoride 
(PVDF) membranes. Specific antibodies against GRP-
78 (Abcam), CHOP (Cell Signaling Tech), IRAK-2 (Cell 
Signaling Tech), IL-1β (Abcam) and GAPDH (Santa 
Cruz) were used to incubate the membranes at 4  °C for 
12 h. After washed, second antibody conjugated to HRP 
(Santa Cruz) was used to incubate the membranes at 
room temperature for 2  h. Eventually, after developed 
by Super Signal West Pico chemiluminsecence reagent 
(Thermo Scientific), the immunoblots were visualized on 
X-ray films. ImageJ2x software was used to quantify the 
intensities of the immunoblots.
Statistical analysis
Data acquired in this study was presented in a 
(mean ±  SD) manner and further analyzed by software 
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SPSS (version 17.0, SPSS). Differences between groups 
were analyzed by one- way analysis of variance (ANOVA) 
followed by a LSD test. P < 0.05 was considered statisti-
cally significant.
Results
IL‑1β level in myocytes was not elevated by high‑ glucose 
incubation
As shown in Fig.  2A, after high-glucose incubation, the 
IL-1β level in myocytes was not elevated significantly. 
Suggesting the myocytes were not the source of IL-1β 
production under circumstances of DCM.
High- glucose mediated ER stress- induced apoptosis 
was elevated by IL-1β which was inhibited by IRAK-2 
silencing.
The apoptosis of isolated myocytes was evaluated 
by both Hoechst and TUNEL staining. The results of 
TUNEL staining were demonstrated in Fig.  3A while 
the results of Hoechst staining were demonstrated in 
Fig.  3B. After high- glucose incubation, GRP-78 and 
CHOP expression levels as well as the apoptotic rate 
increased significantly. Extra IL-1β further boosted 
GRP-78 and CHOP expression levels as well as the 
apoptotic rate. However, the IRAK-2 silenced myocytes 
Fig. 1 A The right side of A demonstrated immunoblots of IRAK-2 and GAPDH in protein extracted from cardiac tissue from control rats, DCM rats, 
DCM rats received IL-1Ra administration at dosages of 1.0, 5.0, 7.5, 10.0 and 15.0 mg/Kg respectively daily for 1 week. Columns on the right part 
indicated the relative expression levels of IRAK-2 [hash differences were significant when compared with control rats (p < 0.05); asterisk differences 
were significant when compared with previous dosages (p < 0.05)]. B demonstrated the immunoblots of IL-1β, GRP-78, IRAK-2, CHOP and GAPDH 
in myocardial tissue in Ctrl, DCM and DCM + IL-1Ra respectively. Columns on the right side indicated the relative expression levels of IL-1β, GRP-78, 
IRAK-2 and CHOP (normalized to GAPDH) respectively. C Captured images demonstrated TUNEL staining in myocardial tissue harvested from Ctrl, 
DCM and DCM + IL-1Ra respectively. The red arrows are pointing at TUNEL-positive cells. Columns on the right side indicated the percentage of 
TUNEL-positive cells in Ctrl, DCM and DCM + IL-1Ra respectively [letter a differences were significant compared with Ctrl (p < 0.05); letter b differ-
ences were significant when compared with DCM (p < 0.05)]
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showed resistance to IL-1β and/or high- glucose incu-
bation- induced CHOP expression elevation and subse-
quent apoptosis without affecting the expression level of 
GRP-78.
IL-1β expression level was found elevated in both cir-
culation and cardiac tissue in DCM rats.
The establishment of DCM rat model was verified by 
fasting blood glucose concentration and impaired cardiac 
function (Fig. 4D). As demonstrated in Fig. 2B, evidenced 
by results from ELISA, the levels of IL-1β was found dra-
matically increased in both serum and cardiac tissue in 
DCM rats.
The IL-1R antagonist, IL-1Ra, significantly improved 
cardiac function in DCM.
As shown in Fig. 4C, the average fasting blood glucose 
concentration of animal received STZ administration was 
higher than 300 mg/dL which was deemed to be diabetic 
in rodents [19, 20]. The cardiac function of DCM was 
also impaired evidenced by elevated LVEDP and reduced 
LVSP (Fig.  4D). However, in DCM rats received IL-1Ra 
administration, the cardiac function was improved sig-
nificantly even with uncontrolled high- fasting glucose 
concentration (Fig. 4D).
IL-1Ra lowered IRAK2/CHOP induced apoptosis in 
DCM heart without affecting circulating and myocardial 
IL-1β levels.
This result was demonstrated in Fig.  1. Compared 
with DCM rats, there were not significant differences 
of expression levels of cardiac GRP78 (Fig.  1B), IL-1β 
(Fig. 2B) and serum IL-1β (Fig. 2B) in DCM rats received 
IL-1Ra administration. However, in cardiac tissue of 
DCM rats administrated with IL-1Ra, the expression 
levels of CHOP and IRAK2 decreased significantly. As a 
result, the cardiac apoptosis of IL-1Ra treated DCM rats 
was dramatically decreased compared with DCM rats.
Discussion
The situation of preventing and treating diabetes is grave 
not only because of the sustained increasing of morbid-
ity of diabetes, but also due to the high mortality resulted 
from various complications of diabetes [21]. It was esti-
mated in the report from the World Health Organization 
(WHO) that there would be over 300 million diabetic 
patients by 2025 [22]. Among the diabetic complications, 
cardiovascular complications were considered the major 
causes responsible for the mortality of diabetes. Inde-
pendent from other cardiovascular diseases including 
congenital heart disease, coronary artery disease, hyper-
tensive heart disease, valvular heart disease and other 
secondary heart diseases, DCM is characterized by car-
diac function impairment and termed as one of the clini-
cal manifestations of diabetes [23].
Uncontrolled and sustained hyperglycemia is the path-
ological basis of both type-1 and type-2 diabetes. It has 
been established that excessive blood glucose impaired 
cardiac function via various mechanisms, of which ER 
stress took indispensable roles in inducing myocytes 
apoptosis, resulting in contractile unit loss [24]. As one 
Fig. 2 A Columns in this figure demonstrated the IL-1β level in supernatant of cultured primary myocytes by ELISA. According to different treat-
ments, equal amount myocytes were divided into Ctrl (control), Scramble (cells transfected with scramble siRNA), HG (cells incubated by medium 
with glucose concentration at 33 mmol/L), HG + IRAK2−/− (cells treated with high-glucose medium and transfected with siRNA targeting irak2), 
HG + IL-1β (cells treated with high-glucose medium and exogenous IL-1β) and HG + IL-1β + IRAK2−/− (cells treated with high-glucose medium 
and exogenous IL-1β and transfected with siRNA against irak2) respectively [asterisk differences were significant when compared with HG (p < 0.05]. 
B Columns in this part showed the detected IL-1β in serum and myocardial tissue supernatant collected from normal control (Ctrl), DCM rats (DCM) 
and DCM rats received IL-1Ra administration (DCM + IL-1Ra) respectively [letter a differences were significant when compared with Ctrl (p < 0.05)]
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Fig. 3 A Demonstrated the captured images of DAPI, TUNEL and their merged images in cultured myocytes. DAPI staining indicated the location 
of cell nuclei; TUNEL positive cells indicated the apoptotic cells. Column in the left part of a indicated the calculated apoptotic rate of myocytes in 
Ctrl, Scramble, HG, HG + IRAK2−/−, HG + IL-1β and HG + IL-1β + IRAK2−/− respectively. B Demonstrated the captured images of cTnI (conjugated 
with Flour 488), Hoechst and their merged images in cultured myocytes. cTnI positive cells were identified as myocytes; Hoechst positive ones 
were identified as apoptotic cells. Columns in on the right part stood for percentage of Hoechst-positive cells in Ctrl, Scramble, HG, HG + IRAK2−/−, 
HG + IL-1β and HG + IL-1β + IRAK2−/− respectively. C demonstrated the immunoblots of GRP-78, IRAK-2, CHOP, IL-1β and GAPDH respectively in 
total protein extracted from myocytes. Columns on the right part of the figure demonstrated the relative expression levels (normalized to GAPDH) 
of GRP-78, IRAK-2, CHOP and IL-1β in Ctrl, Scramble, HG, HG + IRAK2−/−, HG + IL-1β and HG + IL-1β + IRAK2−/− respectively [letter a differences 
were significant when compared with Ctrl (p < 0.05); letter b differences were significant compared with Scramble; letter c differences were signifi-
cant compared with HG (p < 0.05); letter d differences were significant compared with HG + IL-1β (p < 0.05)]
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of the characterized cardiovascular complications of dia-
betes, DCM was found closely associated with ER stress 
[25]. Recently, ER stress and inflammation have been 
linked to various human diseases because effectors and 
regulators are extensively shared by ER stress and inflam-
matory signaling pathways which were found to exacer-
bate cell apoptosis and dysfunctions in a “vicious cycle” 
[26]. More and more evidences suggest that islet β-cell 
dysfunction and loss would induce oxidative stress, glu-
cotoxicity, lipotoxicity, mitochondrial dysfunction and 
inflammation [27–30]. It is hard to decide which of the 
mechanisms is the most dominant, but inflammation is 
confirmed closely associated with DCM [31]. Thus, it is 
reasonable to believe that DCM belongs to the inflamma-
tory diseases.
Among the pro-inflammatory cytokines, IL-1 was 
found particularly important to diabetes because most 
elevated circulating pro-inflammatory factors in diabetic 
patients were considered IL-1 dependent, and IL-1 block-
ing was reported to reduce their circulating concentra-
tions [32]. Generally, IL-1 is suggested as the product of 
immunocytes such as T cells, but β-cell produced IL-1β 
was also observed in pancreatic secretions from patients 
with diabetes [33]. It was also found that hyperglycemia 
yielded the IL-1β production from human islet β-cells, 
resulting in decreased β-cell proliferation, increased 
β-cell dysfunction and apoptosis [34]. Bone marrow- 
derived macrophages was reported also contributed 
in IL-1β production in diabetes [35]. In this study, in 
accordance with the above mentioned studies, we also 
observed the elevation of circulating IL-1β in DCM rats. 
However, in high- glucose incubated myocytes, IL-1β 
level was found unchanged. This result indicated that 
myocytes was not the source of IL-1β in DCM. Further-
more, myocardial IL-1β level was elevated in DCM heart, 
suggesting excessively produced IL-1β affected heart via 
circulation.
Applications of antagonists of IL-1β demonstrated 
significant therapeutic effects on diabetic cardiovas-
cular complications both in experimental animals 
[36] and human [37] indicating that IL-1β played 
an important role in initiating and exacerbating 
Fig. 4 A Columns indicated the bodyweight of rats in Ctrl (control), DCM (DCM rat model) and DCM + IL-1Ra (DCM rats received IL-1Ra treatment) 
measured at 0, 4 and 6 weeks after modeling. B Columns indicated the fasting blood glucose concentrations of rats in Ctrl, DCM and DCM + IL-
1Ra measured at 0 week, 4 weeks and 6 weeks after modeling. C Columns stood for the fasting blood glucose concentrations in Ctrl, DCM and 
DCM + IL1Ra measured at 4 weeks after modeling respectively. D columns in this figure demonstrated detected LVSP (white columns) and LVEDP 
(black columns) by hemodynamic examinations in Ctrl, DCM and DCM + IL-1Ra measure at 6 weeks after modeling respectively [letter a differences 
were significantly compared with Ctrl (p < 0.05); letter b differences were significant compared with DCM (p < 0.05)]
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cardiovascular complications of diabetes. IL-1β activates 
its down-stream signaling by binding to its receptor- 
IL-1R. Then the activated receptor binds to the accessory 
protein, AcP, to form IL-1R-AcP complex. The C- termi-
nal death- domain then couples and activates IRAKs to 
initiate tumor necrosis factor receptor associated fac-
tor-6 (TRAF-6) [38], leading to activate down- stream 
apoptotic pathway [39]. Interestingly, a recent study iden-
tified the correlation between ER stress- induced apop-
tosis and IRAK-2. On one hand, the expression level of 
IRAK-2 was elevated under condition of ER stress, on 
the other hand, increased IRAK-2 boosted the expres-
sion of CHOP, leading to cell apoptosis [14]. Rather than 
other two transducers, namely protein kinase RNA- like 
ER kinase (PERK) and activating transcription factor-6 
(ATF-6), inositol requiring enzyme-1 (IRE1) was sup-
posed to be the signaling linking ER stress and IRAK-2 
[14].
In the in  vitro part, the IL-1β incubation exacerbated 
the high- glucose induced myocytes apoptosis though 
increase the expression of IRAK-2 which in turn further 
increased cell death by elevating CHOP expression. In 
irak2 silenced myocytes, however, the aggravating effect 
of IL-1β on ER stress- induced apoptosis was impaired. 
These results indicated that IL-1β promoted ER stress-
induced myocytes apoptosis in DCM via IRAK-2. In the 
in vivo part, after DCM rats were administrated with the 
IL-1Ra, both of CHOP expression and apoptosis were 
alleviated even the hyperglycemia was still sustained and 
the ER stress was not relieved. As a result, the cardiac 
function of DCM rats was significantly improved.
In summary, we could draw several conclusions 
according to the results in the current study. Firstly, car-
diac function was impaired by elevated circulating IL-1β 
which induced myocytes death. Secondly, in DCM, apop-
totic signals were transduced through IL-1β/IRAK2/
CHOP pathway. This pathway could be considered as a 
crosstalk between IL-1 and ER stress signaling. Finally, 
suppressing IL-1β production or signaling could be con-
sidered as potential molecular targets- based therapeutic 
strategies for DCM.
Limitations and prospectives
There are also limitations for the present study. Firstly, in 
this study, in order to investigate the association between 
high glucose environment and pathological mechanisms 
of myocytes apoptosis, STZ injection was used to estab-
lish the animal model of diabetes by inducing islet cell 
lose. However, by this method, instead of type-2 diabe-
tes which is the most common type of diabetes is type-2 
diabetes in human, type-1 diabetes was modeled. Though 
the mechanisms would be much more complex in DCM 
of type-2 diabetes because other factors such as oxidative 
stress and lipid metabolism disorder are involved, fur-
ther investigation should be implemented. Secondly, it 
was not adequate enough to guarantee the solidity of the 
conclusions due to the unavailability of irak2 gene knock-
out animals. We are planning to investigate the molecu-
lar mechanisms of DCM concerning inflammation and 
myocyte apoptosis in type-2 diabetes animal model in 
the very near future. More studies would be carried out 
as soon as we acquire the irak2 knock-out animals.
Conclusions
Results from this study suggest that elevated circulating 
inflammatory cytokine such as IL-1β contributed to the 
cardiac contractile unit loss in diabetic heart, which takes 
responsibility for impairment of cardiac function. Further 
investigation indicates that IL-1β promoted endoplasmic 
reticulum stress- induced myocytes apoptosis through 
IL-1β/IRAK2/CHOP pathway in DCM. These results 
would not only deepen our understanding of mecha-
nisms of DCM, but also provide new clues for choosing 
therapeutic molecular target in the future.
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